TR200402073T4 - Gaba A reseptör olarak benzodiazepin türevleri - Google Patents

Gaba A reseptör olarak benzodiazepin türevleri

Info

Publication number
TR200402073T4
TR200402073T4 TR2004/02073T TR200402073T TR200402073T4 TR 200402073 T4 TR200402073 T4 TR 200402073T4 TR 2004/02073 T TR2004/02073 T TR 2004/02073T TR 200402073 T TR200402073 T TR 200402073T TR 200402073 T4 TR200402073 T4 TR 200402073T4
Authority
TR
Turkey
Prior art keywords
alkyl
phenyl
halogen
hydrogen
alkoxy
Prior art date
Application number
TR2004/02073T
Other languages
English (en)
Turkish (tr)
Inventor
Masciadri Raffaello
William Thomas Andrew
Wichmann Juergen
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of TR200402073T4 publication Critical patent/TR200402073T4/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2004/02073T 2000-11-16 2001-11-08 Gaba A reseptör olarak benzodiazepin türevleri TR200402073T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00124332 2000-11-16

Publications (1)

Publication Number Publication Date
TR200402073T4 true TR200402073T4 (tr) 2004-10-21

Family

ID=8170315

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/02073T TR200402073T4 (tr) 2000-11-16 2001-11-08 Gaba A reseptör olarak benzodiazepin türevleri

Country Status (40)

Country Link
US (1) US6743789B2 (OSRAM)
EP (1) EP1337535B1 (OSRAM)
JP (1) JP4088151B2 (OSRAM)
KR (1) KR100504300B1 (OSRAM)
CN (1) CN1191255C (OSRAM)
AR (1) AR031345A1 (OSRAM)
AT (1) ATE268776T1 (OSRAM)
AU (2) AU2002217007B2 (OSRAM)
BG (1) BG107817A (OSRAM)
BR (1) BR0115393A (OSRAM)
CA (1) CA2427576C (OSRAM)
CZ (1) CZ295256B6 (OSRAM)
DE (1) DE60103776T2 (OSRAM)
DK (1) DK1337535T3 (OSRAM)
EC (1) ECSP034607A (OSRAM)
ES (1) ES2220831T3 (OSRAM)
GC (1) GC0000375A (OSRAM)
GT (1) GT200100230A (OSRAM)
HR (1) HRP20030360A2 (OSRAM)
HU (1) HUP0303281A3 (OSRAM)
IL (1) IL155813A0 (OSRAM)
JO (1) JO2359B1 (OSRAM)
MA (1) MA26962A1 (OSRAM)
MX (1) MXPA03004251A (OSRAM)
MY (1) MY141675A (OSRAM)
NO (1) NO324706B1 (OSRAM)
NZ (1) NZ525413A (OSRAM)
PA (1) PA8532401A1 (OSRAM)
PE (1) PE20020583A1 (OSRAM)
PL (1) PL362925A1 (OSRAM)
PT (1) PT1337535E (OSRAM)
RU (1) RU2278865C2 (OSRAM)
SI (1) SI1337535T1 (OSRAM)
SK (1) SK7232003A3 (OSRAM)
TR (1) TR200402073T4 (OSRAM)
TW (1) TWI239333B (OSRAM)
UY (1) UY27026A1 (OSRAM)
WO (1) WO2002040487A2 (OSRAM)
YU (1) YU35603A (OSRAM)
ZA (1) ZA200303435B (OSRAM)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
JP4616770B2 (ja) * 2003-06-19 2011-01-19 第一三共株式会社 選択的なアミノ置換基導入法
ES2515092T3 (es) 2003-12-11 2014-10-29 Sunovion Pharmaceuticals Inc. Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión
AU2005272627A1 (en) 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
WO2006040038A1 (en) 2004-10-12 2006-04-20 F.Hoffmann-La Roche Ag Imidazo [1, 5-a]triazolo[1, 5-d]benzodiazepine derivatives for the treatment of cognitive disorders
JP4783375B2 (ja) 2004-10-20 2011-09-28 エフ.ホフマン−ラ ロシュ アーゲー イミダゾベンゾジゼピン誘導体
CA2584757C (en) 2004-10-20 2012-07-03 F. Hoffmann-La Roche Ag Halogen substituted benzodiazepine derivatives
DE602005007265D1 (de) * 2004-12-14 2008-07-10 Hoffmann La Roche Tetrazyklische imidazobenzodiazepine als gaba-rezeptormodulatoren
WO2007019312A2 (en) * 2005-08-03 2007-02-15 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
US8510055B2 (en) 2005-08-03 2013-08-13 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
JP4885967B2 (ja) * 2005-10-11 2012-02-29 エフ.ホフマン−ラ ロシュ アーゲー イミダゾベンゾジアゼピン誘導体
AU2006308889A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US9156836B2 (en) * 2008-05-16 2015-10-13 Synta Pharmaceuticals Corp. Tricyclic triazole compounds that modulate HSP90 activity
MX2011005119A (es) 2008-11-18 2011-05-30 Hoffmann La Roche Alquilciclohexileteres de dihidrotetraazabenzoazulenos.
JP5452608B2 (ja) * 2008-11-28 2014-03-26 エフ.ホフマン−ラ ロシュ アーゲー バソプレシン介在受容体アンタゴニストとしての使用のためのジヒドロテトラアザベンゾアズレンのアリールシクロヘキシルエーテル
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
DK2640391T3 (da) 2010-11-15 2016-02-15 Agenebio Inc Pyridazinderivater, sammensætninger og fremgangsmåder til behandling af kognitiv svækkelse
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
CA2885148A1 (en) * 2012-09-21 2014-03-27 Uwm Research Foundation, Inc. Novel gabaa agonists and methods of using to control airway hyperresponsiveness and inflammation in asthma
EP4032889A1 (en) * 2013-12-20 2022-07-27 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
MA42624A (fr) * 2015-06-19 2021-04-28 Agenebio Inc Dérivés de benzodiazépine, compositions et méthodes de traitement de la déficience cognitive
US10059718B2 (en) * 2016-01-04 2018-08-28 Tabomedex Biosciences, LLC Fused quadracyclic compounds, compositions and uses thereof
US10973479B2 (en) 2016-05-16 2021-04-13 Canon Medical Systems Corporation X-ray diagnosis apparatus, X-ray diagnosis apparatus controlling method, and X-ray diagnosis system
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
CN112601749B (zh) * 2018-06-19 2024-03-26 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂环庚三烯衍生物,组合物和方法
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창
CN112979658B (zh) * 2021-02-22 2022-05-31 南湖实验室 一种氟马西尼的制备方法
WO2024039886A1 (en) 2022-08-19 2024-02-22 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174086D0 (da) 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
TW201311B (OSRAM) 1991-06-17 1993-03-01 Hoffmann La Roche

Also Published As

Publication number Publication date
TWI239333B (en) 2005-09-11
PT1337535E (pt) 2004-09-30
MA26962A1 (fr) 2004-12-20
ES2220831T3 (es) 2004-12-16
AU2002217007B2 (en) 2006-11-30
YU35603A (sh) 2006-05-25
KR100504300B1 (ko) 2005-07-28
JO2359B1 (en) 2006-12-12
HUP0303281A3 (en) 2005-05-30
DE60103776T2 (de) 2005-07-14
PL362925A1 (en) 2004-11-02
MY141675A (en) 2010-06-15
GC0000375A (en) 2007-03-31
DE60103776D1 (de) 2004-07-15
WO2002040487A3 (en) 2002-09-26
GT200100230A (es) 2002-07-04
SI1337535T1 (en) 2004-10-31
RU2003116895A (ru) 2005-02-20
PA8532401A1 (es) 2002-08-26
AR031345A1 (es) 2003-09-17
ECSP034607A (es) 2003-06-25
JP2004517070A (ja) 2004-06-10
JP4088151B2 (ja) 2008-05-21
EP1337535A2 (en) 2003-08-27
NO20032208D0 (no) 2003-05-15
CZ20031597A3 (cs) 2003-11-12
HRP20030360A2 (en) 2005-04-30
HK1062442A1 (en) 2004-11-05
EP1337535B1 (en) 2004-06-09
ZA200303435B (en) 2004-08-05
BG107817A (bg) 2004-07-30
CA2427576C (en) 2007-11-06
BR0115393A (pt) 2004-07-06
ATE268776T1 (de) 2004-06-15
CA2427576A1 (en) 2002-05-23
NZ525413A (en) 2005-02-25
HUP0303281A2 (hu) 2004-01-28
CN1474820A (zh) 2004-02-11
DK1337535T3 (da) 2004-10-25
US6743789B2 (en) 2004-06-01
UY27026A1 (es) 2002-06-20
NO20032208L (no) 2003-05-15
WO2002040487A2 (en) 2002-05-23
KR20030045192A (ko) 2003-06-09
CN1191255C (zh) 2005-03-02
CZ295256B6 (cs) 2005-06-15
MXPA03004251A (es) 2003-09-22
PE20020583A1 (es) 2002-07-06
US20020103371A1 (en) 2002-08-01
SK7232003A3 (en) 2004-03-02
RU2278865C2 (ru) 2006-06-27
NO324706B1 (no) 2007-12-03
AU1700702A (en) 2002-05-27
IL155813A0 (en) 2003-12-23

Similar Documents

Publication Publication Date Title
TR200402073T4 (tr) Gaba A reseptör olarak benzodiazepin türevleri
DK1200390T3 (da) Fremstilling af N-substituerede 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoylamider
PE20080257A1 (es) Derivados de triazol ii
CO4770975A1 (es) Derivados de quinazolina sustituidos
CO5560560A2 (es) Preparacion y uso de derivados de imidazol para el tratamiento de la obesidad
NZ513561A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
CY1109835T1 (el) Πυρανονες χρησιμες ως αναστολεις της atm
CO5271675A1 (es) Derivados de decahidro-isoquinolinas, proceso para su preparacion, composicion y compuestos farmaceuticos que los contienen
HU9501622D0 (en) 1,4-benzodiazepine derivatives and their use as cck-mudulators
WO2002044153A8 (en) 4-6-diphenyl pyridine derivatives as antiinflammatory agents
NO964698D0 (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
HRP20040230B1 (hr) Agonisti muskarina
CO5080801A1 (es) Inhibidores de proteasas
ATE229996T1 (de) Starkes grünstichiges gelbes disazopigment
MXPA04003278A (es) Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina.
DE68913365D1 (de) 4-Amino-3-carboxynaphthyridin-Derivate, ihre Herstellung und pharmazeutische Zusammensetzungen.
MXPA03009158A (es) Azepinas y diazepinas bi y triciclicas substituidas de n-bifenilcarbonil y n-fenilpiridilcarbonil como agonistas de la vasopresion.
EA200200973A1 (ru) Пиридазинилфенилгидразоны, применяемые при застойной сердечной недостаточности
ES2010089A6 (es) Procedimiento para la obtencion de n-oxidos de gamma-carbolina antipsicoticos.
EP1619040A3 (en) Thermal transfer recording material and thermal transfer recording method
CO5180634A1 (es) Sulfonamidas sustituidas con naftilo
CA2361390A1 (en) Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
ZA938230B (en) Substituted benzyl carbamates with herbicidal properties
NZ513724A (en) Anticonvulsant derivatives useful in treating essential tremor